Ibandronate Sodium
Product Images NDC 67457-524

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 67457-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Carton (Image 02)

Carton (Image 02)
Ibandronate Sodium is an injectable medication with NDC 67457-524-33. It is to be used intravenously only and comes in a Mylan single-dose prefilled syringe. The medication guide enclosed should be given to each patient. The concentration is 1 mg/mL. It is available as a sterile Rx-only single-dose prefilled syringe.*
FDA Label Image

Infusion Set (Image 04)

FDA Label Image

Figure-1 (Image 06)

Figure-1 (Image 06)
This is a summary of a comparison between different doses of a medication for increasing bone mineral density in the lumbar spine. The two doses compared are 2.5 mg taken once daily and 3 mg taken every three months either orally or intravenously. The study found a significant difference (p<0.001) between the two doses.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.